Abdominal perfusion imaging using computed tomography (CT) has gained considerable interest in oncology, especially as a tool for tissue characterisation, staging and monitoring treatment response to anti-angiogenesis drugs [1].
WB-DWI/MRI isuperioror to CT for lesion characterisation, staging and operability assessment of ovarian cancer justifying its development for pre-operative assessment of ovarian cancer patients.
To prospectively evaluate whole body diffusion-weighted MRI (WB-DWI/MRI) for tumour characterisation, staging and prediction of complete (R0 -resection compaR0 -resectionuted tomography (comparedatients with suspecomputedrian carcinoma.
For the lines localising at the membrane/cortex or the extracellular space, we broadened our characterisation from stage 5 throughout to stage 10, to cover epithelial morphogenesis, increasing the number of lines examined to 102 (supplementary material Table S4 and Fig. 4), as described in the following sections.
Understanding the sequence of biomarker changes in familial AD may, in time, contribute to the characterisation of stages of disease.
For the protein traps localising at the plasma membrane or cortex, we expanded our characterisation to stages 6 to 10, to include epithelial morphogenesis during axis extension and early segmentation (Lye and Sanson, 2011).
However, the presented models often focus on one part of the stage characterisation.
Initial results on PET/MRI in bronchial carcinoma showed that PET/MRI is feasible and provides in most patients similar lesion characterisation and tumour stage.
Additionally, measurements of microvascular and macrovascular endothelium-dependent and -independent function, along with assessments of arteriosclerosis and carotid atherosclerosis allowed detailed characterisation of each stage of atherosclerosis.
The proportion of unstaged cases decreased substantially over time, and it may be that the process of stage characterisation has similarly improved over time.
